NortonLifeLock (NLOK) Competitors $27.32 -0.18 (-0.65%) As of 02/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsSustainabilityTrends NLOK vs. BTX, and ALFIWShould you be buying NortonLifeLock stock or one of its competitors? The main competitors of NortonLifeLock include Brooklyn ImmunoTherapeutics (BTX), and Alfi (ALFIW). These companies are all part of the "information" sector. NortonLifeLock vs. Brooklyn ImmunoTherapeutics Alfi Brooklyn ImmunoTherapeutics (NYSE:BTX) and NortonLifeLock (NASDAQ:NLOK) are both information companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking. Does the media prefer BTX or NLOK? In the previous week, Brooklyn ImmunoTherapeutics and Brooklyn ImmunoTherapeutics both had 1 articles in the media. Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled NortonLifeLock'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brooklyn ImmunoTherapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NortonLifeLock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in BTX or NLOK? 26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. Comparatively, 94.9% of NortonLifeLock shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by company insiders. Comparatively, 3.3% of NortonLifeLock shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor BTX or NLOK? NortonLifeLock received 89 more outperform votes than Brooklyn ImmunoTherapeutics when rated by MarketBeat users. Likewise, 100.00% of users gave NortonLifeLock an outperform vote while only 0.00% of users gave Brooklyn ImmunoTherapeutics an outperform vote. CompanyUnderperformOutperformBrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes107100.00% NortonLifeLockOutperform Votes89100.00% Underperform VotesNo Votes Which has higher valuation & earnings, BTX or NLOK? NortonLifeLock has higher revenue and earnings than Brooklyn ImmunoTherapeutics. Brooklyn ImmunoTherapeutics is trading at a lower price-to-earnings ratio than NortonLifeLock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-3.38NortonLifeLock$2.82B5.54$817.05M$1.4319.10 Is BTX or NLOK more profitable? Company Net Margins Return on Equity Return on Assets Brooklyn ImmunoTherapeuticsN/A N/A N/A NortonLifeLock N/A N/A N/A Which has more risk & volatility, BTX or NLOK? Brooklyn ImmunoTherapeutics has a beta of 4.61, suggesting that its share price is 361% more volatile than the S&P 500. Comparatively, NortonLifeLock has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. SummaryNortonLifeLock beats Brooklyn ImmunoTherapeutics on 6 of the 8 factors compared between the two stocks. Get NortonLifeLock News Delivered to You Automatically Sign up to receive the latest news and ratings for NLOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NLOK vs. The Competition Export to ExcelMetricNortonLifeLockData Processing, Hosting, and Related Services IndustryInformation SectorNASDAQ ExchangeMarket Cap$15.61B$15.61B$5.38B$8.98BDividend Yield2.31%2.31%3.69%3.85%P/E Ratio19.109.558.5318.82Price / Sales5.545.545.5480.30Price / CashN/AN/AN/A37.47Price / BookN/AN/AN/A4.64Net Income$817.05MN/AN/A$245.69M7 Day Performance-2.50%-1.25%366.08%-2.66%1 Month PerformanceN/AN/A219.57%-2.15%1 Year Performance26.77%13.39%57.21%12.90% NortonLifeLock Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NLOKNortonLifeLock0.8985 of 5 stars$27.32-0.7%N/A+26.8%$15.61B$2.82B19.10N/ABTXBrooklyn ImmunoTherapeuticsN/A$0.34-1.2%N/A+369.1%$19.75MN/A-0.15N/AAnalyst ForecastALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040 Related Companies and Tools Related Companies Brooklyn ImmunoTherapeutics Competitors Alfi Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NLOK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NortonLifeLock Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share NortonLifeLock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NLOK Stock Alerts